Influence of anatomical subsite on the incidence of microsatellite instability, and KRAS and BRAF mutation rates in patients with colon carcinoma

Pathology Research and Practice

Volumn 208, Issue 10, 2012, Pages 592-597

  Benedix, Frank ^a   Meyer, Frank ^a   Kube, Rainer ^b   Kropf, Siegfried ^a   Kuester, Doerthe ^a   Lippert, Hans ^a   Roessner, Albert ^a   Krüger, Sabine ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b Carl Thiem Hospital Cottbus   (Germany)

Author keywords

BRAF mutation; Colon carcinoma; Colonic subsite; KRAS mutation; MSI

Indexed keywords

B RAF KINASE; K RAS PROTEIN; TUMOR MARKER;

ADULT; AGED; ANATOMICAL VARIATION; ARTICLE; BRAF GENE; CANCER GRADING; CANCER INCIDENCE; CANCER STAGING; CLINICAL FEATURE; COLON CARCINOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DISTANT METASTASIS; FEMALE; GENE IDENTIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; MUTATIONAL ANALYSIS; ONCOGENE; ONCOGENE K RAS; PRIMARY TUMOR; RETROSPECTIVE STUDY; TUMOR LOCALIZATION;

AGED; AGED, 80 AND OVER; CARCINOMA; CELL DIFFERENTIATION; CHI-SQUARE DISTRIBUTION; COLONIC NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MUTATION; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PHENOTYPE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS; RETROSPECTIVE STUDIES;

EID: 84867628245     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2012.07.003     Document Type: Article

References (28)

1. Andreyev H.J., Norman A.R., Cunningham D., Oates J.R., Clarke P.A. Kirsten ras mutations in patients with colorectal cancer: the multicenter 'RASCAL' study. J. Natl. Cancer Inst. 1998, 90:675-684.
2. Andreyev H.J., Norman A.R., Cunningham D., et al. Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br. J. Cancer 2001, 85:692-696.
3. Arai T., Kino I. Morphometrical and cell kinetic studies of normal human colorectal mucosa. Comparison between the proximal and the distal large intestine. Acta Pathol. Jpn 1989, 39:725-730.
4. Araki K., Furuya Y., Kobayashi M., Matsuura K., Ogata T., Isozaki H. Comparison of mucosal microvasculature between the proximal and distal human colon. J. Electron Microsc. (Tokyo) 1996, 45:202-206.
5. Benedix F., Kube R., Meyer F., Schmidt U., Gastinger I., Lippert H., Colon/Rectum Carcinomas (Primary Tumor) Study Group Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival. Dis. Colon Rectum 2010, 53:57-64.
6. Benedix F., Schmidt U., Mroczkowski P., Gastinger I., Lippert H., Kube R. Colon carcinoma - classification into right and left sided cancer or according to colonic subsite? - Analysis of 29,568 patients. Eur. J. Surg. Oncol. 2011, 37:134-139.
7. Bleeker W.A., Hayes V.M., Karrenbeld A., et al. Impact of KRAS and TP53 mutations on survival in patients with left- and right-sided Dukes' C colon cancer. Am. J. Gastroenterol. 2000, 95:2953-2957.
8. Bufill J.A. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann. Intern. Med. 1990, 113:779-788.
9. Cho Y.K., Kim H.C., Kim S.H., et al. Location-related differences in sporadic microsatellite unstable colorectal cancer. Dig. Liver Dis. 2010, 42:611-615.
10. Chou C.L., Lin J.K., Wang H.S., Yang S.H., Li A.F., Chang S.C. Microsatellite instability screening should be done for right-sided colon cancer patients less than 60 years of age. Int. J. Colorectal Dis. 2010, 25:47-52.
11. Deng G., Kakar S., Tanaka H., et al. Proximal and distal colorectal cancers show distinct gene-specific methylation profiles and clinical and molecular characteristics. Eur. J. Cancer 2008, 44:1290-1301.
12. Fariña-Sarasqueta A., van Lijnschoten G., Moerland E., et al. The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients. Ann. Oncol. 2010, 21:2396-2402.
13. Gervaz P., Bucher P., Morel P. Two colons-two cancers: paradigm shift and clinical implications. J. Surg. Oncol. 2004, 88:261-266.
14. Glebov O.K., Rodriguez L.M., Nakahara K., et al. Distinguishing right from left colon by the pattern of gene expression. Cancer Epidemiol. Biomarkers Prev. 2003, 12:755-762.
15. Li F.Y., Lai M.D. Colorectal cancer, one entity or three. J. Zhejiang Univ. Sci. B 2009, 10:219-229.
16. Maruta M., Kotake K., Maeda K. Colorectal cancer in Japan. Rozhl. Chir. 2007, 86:618-621.
17. Minoo P., Zlobec I., Peterson M., Terracciano L., Lugli A. Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles. Int. J. Oncol. 2010, 37:707-718.
18. Nash G.M., Gimbel M., Cohen A.M., et al. KRAS mutation and microsatellite instability: two genetic markers of early tumor development that influence the prognosis of colorectal cancer. Ann. Surg. Oncol. 2010, 17:416-424.
19. Nawa T., Kato J., Kawamoto H., et al. Differences between right- and left-sided colon cancer in patient characteristics, cancer morphology and histology. J. Gastroenterol. Hepatol. 2008, 23:418-423.
20. Papagiorgis P., Oikonomakis I., Karapanagiotou I., Wexner S.D., Nikiteas N. The impact of tumor location on the histopathologic expression of colorectal cancer. J. BUON 2006, 11:317-321.
21. Perea J., Alvaro E., Rodríguez Y., et al. Approach to early-onset colorectal cancer: clinicopathological, familial, molecular and immunohistochemical characteristics. World J. Gastroenterol. 2010, 16:3697-3703.
22. Rampazzo E., Bertorelle R., Serra L., et al. Relationship between telomere shortening, genetic instability, and site of tumour origin in colorectal cancers. Br. J. Cancer 2010, 102:1300-1305.
23. Roth A.D., Tejpar S., Delorenzi M., et al. Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial. J. Clin. Oncol. 2010, 28:466-474.
24. Saltzstein S.L., Behling C.A. Age and time as factors in the left-to-right shift of the subsite of colorectal adenocarcinoma: a study of 213,383 cases from the California Cancer Registry. J. Clin. Gastroenterol. 2007, 41:173-177.
25. Sinicrope F.A., Rego R.L., Foster N., et al. Microsatellite instability accounts for tumor site-related differences in clinicopathologic variables and prognosis in human colon cancers. Am. J. Gastroenterol. 2006, 101:2818-2825.
26. Skinner S.A., O'Brien P.E. The microvascular structure of the normal colon in rats and humans. J. Surg. Res. 1996, 61:482-490.
27. Tie J., Gibbs P., Lipton L., et al. Optimizing targeted therapeutic development: analysis of a colorectal cancer patient population with the BRAF(V600E) mutation. Int. J. Cancer 2011, 128:2075-2084.
28. Zlobec I., Bihl M.P., Schwarb H., Terracciano L., Lugli A. Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis. Int. J. Cancer 2010, 127:367-380.